Preventive Care
Conference Coverage
‘Smart’ stethoscope spots peripartum cardiomyopathy
Finding that 4% of the women in the intervention arm had reduced ejection fraction is “absolutely startling ... and speaks to how important...
Latest News
PREVENT: AHA’s new risk calculator incorporates CKM health
PREVENT is for use in adults aged 30-79 years and estimates the 10- and 30-year risk of total CVD including, for the first time, heart failure.
From the Journals
WHO: Smoking cessation reduces risk of type 2 diabetes up to 40%
Key misconceptions among smokers with type 2 diabetes that can prevent cessation include concerns about post-cessation weight gain, the influence...
Latest News
Sleeping beats sitting? What a new study means for your patients
“Our study highlights that replacing sedentary behavior with any other behavior can be beneficial.”
Latest News
‘Love more’: Why doctors should promote social connection
Embracing community and close relationships helps people live longer and be happier.
Conference Coverage
Pharmacist-based strategy places more patients on statins
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing...
Conference Coverage
Better postpartum BP control with self-monitoring: POP-HT
“This trial identifies a potential need for a paradigm shift in the way women affected by hypertensive pregnancy are managed postnatally,” said Dr...
Conference Coverage
Apixaban cuts stroke but ups bleeding in subclinical AFib: ARTESIA
The big question is whether the reduction in stroke with anticoagulation outweighs the increase in major bleeding.
Conference Coverage
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Conference Coverage
Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?
The ongoing prospective multicenter trial is the largest of its kind.
Conference Coverage
Semaglutide ‘a new pathway’ to CVD risk reduction: SELECT
The SELECT trial was “a turning point in the treatment of obesity and a call to action.”